Healthcare

High-end Refractometer Market worth $0.38 billion by 2032 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Dec. 9, 2025, 10:15 GMT-05

MarketsandMarkets

Read full article →

Clinical Trial Shows Pycnogenol® Significantly Relieves Lipedema Symptoms and Improves Quality of Life in Women

GENEVA, Dec. 9, 2025, 09:00 GMT-05

HorphagResearch-Trial

Read full article →

ACTO'S CXZONE WINS DUAL HONORS IN THE 2025 PHARMACEUTICAL TECHNOLOGY EXCELLENCE AWARDS

TORONTO and NEW YORK, Dec. 9, 2025, 08:30 GMT-05

ACTO-HONORS

Read full article →

Fibrocor Therapeutics appoints world-leading nephrologists to Clinical Advisory Board with a focus on its lead indication Alport Syndrome

TORONTO and LEUVEN, Belgium, Dec. 9, 2025, 03:30 GMT-05

Fibrocor-Therapeutics

Read full article →

Leqembi included in China's commercial insurance innovative drug list

STOCKHOLM, Dec. 8, 2025, 18:44 GMT-05

BioArctic

Read full article →

Acute on Chronic Liver Failure Market Set to Grow by 2034 as Novel Therapeutic Approaches Enter Clinical Pipeline | DelveInsight

LAS VEGAS, Dec. 8, 2025, 17:31 GMT-05

DelveInsightResearch

Read full article →

Cardiovascular Diagnostic Device Market to Reach $21.1 billion, Globally, by 2034 at 7.2% CAGR: Allied Market Research

WILMINGTON, Del., Dec. 8, 2025, 11:22 GMT-05

Allied-Market-Report

Read full article →

Nutraceutical Excipients Market Driven by Expanding Dietary Supplement Demand and Advanced Formulation Technologies - Market Research Intellect

LEWES, Del., Dec. 8, 2025, 10:50 GMT-05

MARKETRESEARCHINTELLE

Read full article →

Exosomes Market Led by North America with 53% Revenue Share and Global Market Size Set to Surpass USD 2B by 2030, Says Mordor Intelligence

HYDERABAD, India, Dec. 8, 2025, 05:35 GMT-05

MordorIntelligence

Read full article →

Servier's Voranigo® (vorasidenib) Receives Prix Galien Awards Across Multiple Regions

SURESNES, France, Dec. 8, 2025, 05:14 GMT-05

Servier-Awards

Read full article →

The impact of avoiding recurrence: New BRAVO Study abstract at SUO 2025 demonstrates Cost Neutrality in Blue Light versus White Light Cystoscopy comparison

OSLO, Norway, Dec. 8, 2025, 02:30 GMT-05

PHOTOCURE-BRAVO-study

Read full article →

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder

BRUSSELS, Dec. 8, 2025, 01:32 GMT-05

UCB-GMEZ-Phase3

Read full article →

HCMCT Manipal Hospitals Delhi, India performs lifesaving heart transplant on a 54-year-old woman

NEW DELHI, Dec. 8, 2025, 00:59 GMT-05

HCMCT-Manipal

Read full article →

Sobi to Showcase Scientific advances and Commitment to Haematology at ASH 2025

STOCKHOLM, Dec. 5, 2025, 12:46 GMT-05

SOBI-ASH-2025

Read full article →

Life Sciences BPO Market is expected to generate a revenue of USD 481.8 Billion by 2032, Globally, at 7.50% CAGR: Verified Market Research®

LEWES, Del., Dec. 5, 2025, 10:50 GMT-05

Verified-Market

Read full article →

Clinical Chemistry Analyzers Market worth $20.86 billion by 2030 | MarketsandMarkets™

DELRAY BEACH, Fla., Dec. 5, 2025, 10:30 GMT-05

MARKETSANDMARKETS

Read full article →

Basal Cell Carcinoma Market Poised for Steady Growth Throughout Forecast Period (2025-2034) Driven by Novel Drug Approvals and Expanding Patient Pool | DelveInsight

LAS VEGAS, Dec. 4, 2025, 17:31 GMT-05

DelveInsight

Read full article →

Islamic Civilization Center in Uzbekistan Awarded Prestigious International Prix Avicenne 2025 award

TASHKENT, Uzbekistan, Dec. 4, 2025, 07:37 GMT-05

Islamic-Uzbekistan

Read full article →

Generic Injectables Market Dominated by Hospital Pharmacies with 61.23% Share as Online Pharmacies Surge at 18.06% CAGR Through 2030, Reports Mordor Intelligence

HYDERABAD, India, Dec. 4, 2025, 04:44 GMT-05

Mordor-Intelligence

Read full article →

Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda® biosimilar candidate FYB206 for the MENA Region

PLANEGG-MARTINSRIED, Germany and AMMAN, Jordan, Dec. 4, 2025, 04:16 GMT-05

MS-PHARMA-Formycon

Read full article →